| 药品名称 | ONCOVIN | | 申请号 | 014103 | 产品号 | 002 | | 活性成分 | VINCRISTINE SULFATE | 市场状态 | 停止上市 | | 剂型或给药途径 | INJECTABLE;INJECTION | 规格 | 5MG/VIAL | | 治疗等效代码 | | 参比药物 | 否 | | 批准日期 | Approved Prior to Jan 1, 1982 | 申请机构 | ELI LILLY AND CO
| | 化学类型 | New molecular entity (NME) | 审评分类 | Priority review drug |
|
|
| 与本品相关的专利信息（来自橙皮书Orange Book） | | 专利号 | 专利过期日 | 是否化合物专利 | 是否产品专利 | 专利用途代码 | 专利下载 | | 无 | | 历史专利信息 | | 无 |
|
| 与本品相关的市场独占权保护信息 | | 独占权代码 | 失效日期 | | 无 | | 历史市场独占权保护信息 | | 无 |
|
| 与药品注册相关的信息 | | 申请号 | 修订号 | 审批结论 | 公开文档类型 | 文档创建时间 | 获取文档 | | 无 |
|
| 药品注册审批历史信息 | | 申请号 | 修订号 | 审批结论 | 审批日期 | 审批内容 | | 014103 | 062 | AP | 2001/01/02 | Control Supplement | | 014103 | 060 | AP | 1999/08/26 | Labeling Revision | | 014103 | 059 | AP | 1998/04/29 | Manufacturing Change or Addition | | 014103 | 058 | AP | 1997/10/03 | Control Supplement | | 014103 | 055 | AP | 1995/11/06 | Manufacturing Change or Addition | | 014103 | 053 | AP | 1996/03/28 | Package Change | | 014103 | 052 | AP | 1995/07/05 | Manufacturing Change or Addition | | 014103 | 051 | AP | 1992/12/16 | Labeling Revision | | 014103 | 050 | AP | 1992/06/30 | Labeling Revision | | 014103 | 049 | AP | 1992/04/02 | Labeling Revision | | 014103 | 048 | AP | 1991/01/02 | Package Change | | 014103 | 047 | AP | 1991/04/23 | Control Supplement | | 014103 | 046 | AP | 1990/06/14 | Labeling Revision | | 014103 | 044 | AP | 1989/06/06 | Labeling Revision | | 014103 | 043 | AP | 1988/09/16 | Labeling Revision | | 014103 | 042 | AP | 1988/06/22 | Package Change | | 014103 | 040 | AP | 1988/04/05 | Labeling Revision | | 014103 | 039 | AP | 1987/08/17 | Labeling Revision | | 014103 | 038 | AP | 1987/07/23 | Control Supplement | | 014103 | 037 | AP | 1987/02/19 | Manufacturing Change or Addition | | 014103 | 036 | AP | 1986/01/27 | Labeling Revision | | 014103 | 035 | AP | 1986/03/17 | Labeling Revision | | 014103 | 033 | AP | 1985/08/16 | Control Supplement | | 014103 | 031 | AP | 1985/09/23 | Labeling Revision | | 014103 | 030 | AP | 1984/03/07 | Labeling Revision | | 014103 | 029 | AP | 1983/09/20 | Control Supplement | | 014103 | 027 | AP | 1985/05/31 | Control Supplement | | 014103 | 026 | AP | 1982/05/10 | Labeling Revision | | 014103 | 024 | AP | 1982/12/09 | General Efficacy (MarkIV) | | 014103 | 023 | AP | 1981/07/02 | Control Supplement | | 014103 | 022 | AP | 1981/05/15 | Labeling Revision | | 014103 | 021 | AP | 1982/04/08 | Formulation Revision | | 014103 | 016 | AP | 1976/03/12 | Labeling Revision | | 014103 | 000 | AP | 1963/07/10 | Approval |
|